COVID-19 patients with obesity at risk for worse outcomes despite younger age and fewer inflammatory derangements
2. Zero hunger
Intensive Care Units
SARS-CoV-2
COVID-19
Humans
Original Article
Obesity
Child
Retrospective Studies
3. Good health
DOI:
10.1016/j.soard.2021.06.006
Publication Date:
2021-06-24T13:35:29Z
AUTHORS (6)
ABSTRACT
BackgroundCoronavirus disease 2019 (COVID-19) is a viral pulmonary infection that can progress to cytokine storm syndrome because of widespread dysregulated inflammatory response. Many patients at risk for severe COVID-19 manifestation have been identified as those with preexisting conditions origin, well impair appropriate immune response, such obesity.ObjectivesThe aim this study describe the manifestation, clinical course, and biomarker milieu in obesity.SettingUniversity Hospital Philadelphia, Pennsylvania.MethodsIn retrospective cohort study, 600 who were positive stratified by World Health Organization (WHO) obesity class their presenting symptoms, biomarkers, demographics, outcomes (intubation rate, intensive care unit [ICU] admission, length stay [LOS], mortality) investigated.ResultsAge was inversely related class; III presented 12.9 years younger than normal weight (P < .0001). Initial ferritin lab values negatively correlated increasing = .0192). Normal or near-normal lymphocyte profile noted compared without .0017). Patients had an increased rate ICU admission .0215) .0004), but no differences intubation .3705) mortality .2486).ConclusionPatients more likely present hospital age, reduced levels disturbances, LOS rates, although not mortality.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....